NASDAQ : TNYA
Tenaya Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.3984 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 89.33M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 22.40M | 24.72M | 29.21M | 33.16M | 31.08M | 18.41M |
| Research & Development | 61.61M | 68.61M | 86.74M | 98.04M | 94.54M | 54.39M |
| Operating Expenses | 84.01M | 93.33M | 115.95M | 131.19M | 125.62M | 72.81M |
| Operating Income | -82.68M | -93.33M | -115.95M | -131.19M | -125.62M | -72.81M |
| Interest & Investment Income | 2.72M | 2.68M | 4.74M | 7.06M | 1.95M | 108.00K |
| Other Non Operating Income (Expenses) | -1.34M | 52.00K | 82.00K | 53.00K | 2.00K | -23.00K |
| EBT Excluding Unusual Items | -81.29M | -90.60M | -111.13M | -124.08M | -123.67M | -72.72M |
| Pretax Income | -103.11M | -90.60M | -111.13M | -124.08M | -123.67M | -72.72M |
| Net Income | -103.11M | -90.60M | -111.13M | -124.08M | -123.67M | -72.72M |
| Net Income to Common | -103.11M | -90.60M | -111.13M | -124.08M | -123.67M | -72.72M |
| Shares Outstanding (Basic) | 193.35M | 152.97M | 84.82M | 73.79M | 44.82M | 17.73M |
| Shares Outstanding (Diluted) | 193.35M | 152.97M | 84.82M | 73.79M | 44.82M | 17.73M |
| EPS (Basic) | -0.53 | -0.59 | -1.31 | -1.68 | -2.76 | -4.10 |
| EPS (Diluted) | -0.53 | -0.59 | -1.31 | -1.68 | -2.76 | -4.10 |
| Free Cash Flow | -52.59M | -68.88M | -91.53M | -103.31M | -125.05M | -85.93M |
| Free Cash Flow Per Share | -0.27 | -0.45 | -1.08 | -1.40 | -2.79 | -4.85 |
| EBITDA | -75.52M | -84.89M | -107.48M | -122.51M | -119.15M | -69.84M |
| D&A For EBITDA | 7.15M | 8.44M | 8.47M | 8.69M | 6.47M | 2.96M |
| EBIT | -82.68M | -93.33M | -115.95M | -131.19M | -125.62M | -72.81M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 78.08M | 100.55M | 4.32M | 45.68M | 95.27M | 38.13M |
| Short-Term Investments | 57.12M | 58.96M | 91.25M | 213.17M | ||
| Cash & Short-Term Investments | 78.08M | 100.55M | 61.45M | 104.64M | 186.53M | 251.30M |
| Other Receivables | 2.25M | |||||
| Receivables | 371.00K | 2.25M | ||||
| Prepaid Expenses | 3.48M | 4.01M | 5.09M | 5.78M | 4.04M | 4.06M |
| Other Current Assets | 4.07M | 1.02M | 842.00K | 1.16M | 938.00K | |
| Total Current Assets | 86.01M | 105.59M | 67.38M | 111.58M | 193.75M | 255.36M |
| Property, Plant & Equipment | 5.46M | 37.09M | 47.75M | 53.26M | 62.70M | 54.70M |
| Long-Term Investments | 17.70M | |||||
| Other Long-Term Assets | 2.07M | 4.25M | 4.82M | 5.68M | 4.79M | 4.13M |
| Total Assets | 93.54M | 146.92M | 119.94M | 170.51M | 278.94M | 314.19M |
| Accounts Payable | 2.90M | 3.58M | 5.16M | 5.63M | 9.58M | 10.72M |
| Accrued Expenses | 6.66M | 8.38M | 7.47M | 12.03M | 9.99M | 6.03M |
| Current Portion of Leases | 2.88M | 3.02M | 2.78M | 4.32M | 4.01M | 1.99M |
| Current Income Taxes Payable | 529.00K | 277.00K | 348.00K | 280.00K | ||
| Other Current Liabilities | 324.00K | 176.00K | 214.00K | 478.00K | 669.00K | 3.02M |
| Total Current Liabilities | 19.02M | 15.44M | 15.97M | 22.73M | 24.25M | 21.77M |
| Long-Term Leases | 1.07M | 7.81M | 10.83M | 8.11M | 11.09M | 13.71M |
| Other Long-Term Liabilities | 103.00K | 410.00K | 281.00K | 253.00K | 228.00K | 182.00K |
| Total Liabilities | 24.13M | 23.66M | 27.09M | 31.09M | 35.57M | 35.66M |
| Common Stock | 22.00K | 21.00K | 8.00K | 7.00K | 7.00K | 4.00K |
| Additional Paid-In Capital | 737.06M | 728.25M | 607.23M | 542.80M | 522.95M | 434.20M |
| Retained Earnings | -667.67M | -605.01M | -514.41M | -403.28M | -279.20M | -155.53M |
| Comprehensive Income & Other | 28.00K | -106.00K | -378.00K | -141.00K | ||
| Total Common Equity | 69.41M | 123.27M | 92.85M | 139.42M | 243.38M | 278.53M |
| Shareholders' Equity | 69.41M | 123.27M | 92.85M | 139.42M | 243.38M | 278.53M |
| Total Liabilities & Equity | 93.54M | 146.92M | 119.94M | 170.51M | 278.94M | 314.19M |
| Total Debt | 3.95M | 10.83M | 13.61M | 12.42M | 15.10M | 15.70M |
| Net Cash (Debt) | 74.14M | 89.72M | 47.84M | 92.22M | 189.13M | 235.60M |
| Net Cash Per Share | 0.38 | 0.59 | 0.56 | 1.25 | 4.22 | 13.29 |
| Filing Date Shares Outstanding | 224.23M | 217.00M | 87.58M | 78.52M | 66.87M | 41.29M |
| Total Common Shares Outstanding | 224.23M | 216.76M | 86.54M | 68.33M | 66.86M | 41.29M |
| Working Capital | 66.99M | 90.15M | 51.40M | 88.85M | 169.51M | 233.58M |
| Book Value Per Share | 0.31 | 0.57 | 1.07 | 2.04 | 3.64 | 6.75 |
| Tangible Book Value | 69.41M | 123.27M | 92.85M | 139.42M | 243.38M | 278.53M |
| Tangible Book Value Per Share | 0.31 | 0.57 | 1.07 | 2.04 | 3.64 | 6.75 |
| Machinery | 19.69M | 41.29M | 40.07M | 40.28M | 39.98M | 12.64M |
| Construction In Progress | 67.00K | 1.92M | 1.73M | 3.13M | 32.56M | |
| Leasehold Improvements | 7.79M | 26.24M | 26.16M | 25.61M | 23.61M | 7.24M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -103.11M | -90.60M | -111.13M | -124.08M | -123.67M | -72.72M |
| Depreciation & Amortization | 7.15M | 8.44M | 8.47M | 8.69M | 6.47M | 2.96M |
| Loss (Gain) From Sale of Investments | 111.00K | 411.00K | -184.00K | 315.00K | -307.00K | 131.00K |
| Stock-Based Compensation | 9.58M | 13.05M | 16.50M | 15.31M | 11.47M | 2.95M |
| Other Operating Activities | 3.93M | 2.90M | 3.77M | 3.35M | 2.46M | 1.12M |
| Change in Accounts Payable | -388.00K | -1.43M | -581.00K | -3.28M | 1.66M | 8.60M |
| Change in Other Net Operating Assets | -704.00K | -1.03M | -7.35M | -2.37M | -2.51M | -3.86M |
| Operating Cash Flow | -52.33M | -68.26M | -90.50M | -102.07M | -104.42M | -60.81M |
| Capital Expenditures | -263.00K | -618.00K | -1.02M | -1.24M | -20.63M | -25.12M |
| Investment in Securities | 8.89M | 56.70M | 2.14M | 49.98M | 104.27M | -213.44M |
| Other Investing Activities | 17.00K | -25.00K | 8.00K | |||
| Investing Cash Flow | 8.62M | 56.08M | 1.13M | 48.72M | 83.65M | -238.56M |
| Issuance of Common Stock | 59.53M | 108.41M | 47.75M | 4.55M | 77.77M | 189.00M |
| Repurchase of Common Stock | -13.00K | |||||
| Other Financing Activities | -415.00K | -501.00K | ||||
| Financing Cash Flow | 59.12M | 108.41M | 47.75M | 4.05M | 77.77M | 208.97M |
| Net Cash Flow | 15.41M | 96.22M | -41.62M | -49.31M | 56.99M | -90.41M |
| Free Cash Flow | -52.59M | -68.88M | -91.53M | -103.31M | -125.05M | -85.93M |
| Free Cash Flow Per Share | -0.27 | -0.45 | -1.08 | -1.40 | -2.79 | -4.85 |
| Levered Free Cash Flow | -32.60M | -37.36M | -52.73M | -60.78M | -83.92M | -52.60M |
| Unlevered Free Cash Flow | -32.60M | -37.36M | -52.73M | -60.78M | -83.92M | -52.60M |
| Change in Working Capital | 8.20M | -2.46M | -7.93M | -5.65M | -849.00K | 4.74M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 82.38M | 154.04M | 113.29M | 220.68M | 128.62M | 782.28M |
| Enterprise Value | 8.25M | 109.26M | 48.35M | 104.60M | -4.78M | 518.03M |
| Last Close Price | 0.37 | 0.71 | 1.43 | 3.24 | 2.01 | 18.95 |
| PB Ratio | 1.19 | 1.25 | 1.22 | 1.58 | 0.53 | 2.81 |
| P/TBV Ratio | 1.19 | 1.25 | 1.22 | 1.58 | 0.53 | 2.81 |
| Debt / Equity Ratio | 0.06 | 0.09 | 0.15 | 0.09 | 0.06 | 0.06 |
| Net Debt / Equity Ratio | -1.07 | -0.73 | -0.52 | -0.66 | -0.78 | -0.85 |
| Net Debt / EBITDA Ratio | 0.98 | 1.06 | 0.45 | 0.75 | 1.59 | 3.37 |
| Net Debt / FCF Ratio | 1.41 | 1.30 | 0.52 | 0.89 | 1.51 | 2.74 |
| Quick Ratio | 4.12 | 6.51 | 3.85 | 4.60 | 7.79 | 11.54 |
| Current Ratio | 4.52 | 6.84 | 4.22 | 4.91 | 7.99 | 11.73 |
| Return on Equity (ROE) | -121.86% | -83.84% | -95.69% | -64.83% | -47.39% | -34.80% |
| Return on Assets (ROA) | -47.91% | -43.72% | -49.90% | -36.49% | -26.47% | -19.68% |
| Return on Capital Employed (ROCE) | -110.90% | -71.00% | -111.50% | -88.80% | -49.30% | -24.90% |
| Earnings Yield | -145.16% | -58.81% | -98.10% | -56.23% | -96.15% | -9.30% |
| FCF Yield | -63.83% | -44.72% | -80.79% | -46.81% | -97.23% | -10.98% |
| Buyback Yield / Dilution | -73.58% | -80.34% | -14.96% | -64.61% | -152.75% | -1,724.33% |